Content about Pharmaceutical industry

October 10, 2012
GPhA appoints CVS Caremark public policy director

An executive from CVS Caremark will guide policy for a generic drug industry trade association.

October 10, 2012
Mylan settles suit over asthma, allergy drug

Mylan has settled a patent infringement suit over a drug used to treat respiratory diseases, Mylan said.

October 9, 2012
NCPA survey challenges MAC, audits

Abusive auditing and unfair reimbursement practices harm community pharmacists’ ability to provide critically needed patient counseling and care to seniors, according to a new survey released Sept. 18 by the National Community Pharmacists Association.


October 9, 2012
NewsBytes — Chain Pharmacy, 10/15/12

Drug maker Dr. Reddy’s Labs has launched a generic antibiotic drug, the company said. The India-based company announced the launch of amoxicillin tablets, capsules and oral suspension.

October 9, 2012
Ranbaxy launches authorized generic autoimmune drug

Ranbaxy Labs has launched an authorized generic drug for treating dry mouth associated with an autoimmune disorder, the company said Tuesday.

October 2, 2012
Takeda, Lundbeck seek FDA nod for depression drug

Drug makers Takeda Pharmaceutical and H. Lundbeck have applied with the Food and Drug Administration for a new drug to treat depression in adults.

September 28, 2012
FDA approves two generic hypertension drugs from Mylan

Generic drug maker Mylan has received regulatory approval for a drug used to treat high blood pressure, also known as hypertension, the company said Friday.

September 28, 2012
Health, industry officials look for ways to combat counterfeit drug spread

Keynote speeches by pharmaceutical industry and regulatory leaders got top billing as more than 140 government, healthcare industry, law enforcement and patient advocacy officials gathered to find ways to combat the spread of counterfeit medicines.

September 28, 2012
Patients can't afford to be cheap on medication therapies

Sticker shock is often a major factor in any person's purchasing decisions, but while deciding to put off buying a new car might not have catastrophic consequences, not filling a prescription because it costs too much can.

September 28, 2012
Stiefel psoriasis drug gains additional FDA approval

The Food and Drug Administration has approved a treatment for psoriasis of the scalp made by a subsidiary of British drug maker GlaxoSmithKline.

September 26, 2012
Depomed sues FDA over drug for shingles-related pain

A drug maker is suing the Food and Drug Administration to force the agency to give a special designation to one of its drugs.

September 25, 2012
Pharma strategy moves past product to patient

Walgreens is fundamentally changing the way it does business with both its upstream pharmaceutical suppliers and its downstream customers in the managed care world.

September 25, 2012
Reports: GDUFA implementation may hit delays

The generic drug user fee program may have hit a speed bump due to budget problems in Congress, according to published reports.

September 25, 2012
Valeant buys eye drug for $112.5 million

Valeant Pharmaceuticals International has acquired rights to a drug used to treat a symptom of age-related macular degeneration, the drug maker said.

September 24, 2012
Big pharma's future: Life after the patent cliff

It wasn’t that long ago that the branded drug industry was seen as an unstoppable titan of American industry, churning out a steady stream of breakthrough therapies and blockbuster products. But a tsunami of expiring patents on such top selling drugs as Lipitor, Plavix and Seroquel, combined with a slowdown in research and development, flattened the growth curve in recent years and opened the door for the ascendancy of generic drugs.

September 24, 2012
Sandoz launches authorized generic of Diovan HCT

Generic drug maker Sandoz has launched an authorized generic version of a drug used to treat hypertension.

September 21, 2012
AmerisourceBergen: Pharmaceuticals business has bright future

The pharmaceuticals business will begin picking up in 2014, AmerisourceBergen president and CEO Steve Collis said at the wholesaler's ThinkLive Manufacturer's Summit.

September 21, 2012
Amgen drug approved for osteoporosis in men

The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

September 21, 2012
FDA approves Mylan motion sickness drug

The Food and Drug Administration has approved a generic drug for motion sickness made by Mylan.

September 20, 2012
Alliance Boots acquires stake in Chinese wholesale market

Alliance Boots, under the terms of a strategic alliance agreement signed earlier this week, announced that it will acquire a 12% stake in Nanjing Pharmaceutical for a total consideration of approximately $90.7 million.

September 20, 2012
FDA approves Acton asthma drug

The Food and Drug Administration has approved a drug made by Acton Pharmaceuticals for asthma, the company said Thursday.

September 20, 2012
Sanofi, TB Alliance to collaborate on tuberculosis drugs

French drug maker Sanofi announced a deal with the Global Alliance for TB Drug Development Thursday to develop drugs for tuberculosis.

September 18, 2012
Generics saved U.S. $1 trillion in 9 years

A trillion of anything is difficult to wrap one’s head around, whether it’s the number of grains of sand on a beach or stars in the sky. It’s so much easier for the human mind to look at such a quantity as the sum of its parts rather than on the basis of its individual components.


September 18, 2012
Meijer offers Lipitor generic for free

It’s a little hard not to say “Oh, how the mighty have fallen” when a retailer announces that it will give away for free what was once the world’s top-selling drug. But for retailers, it also makes good business sense.


September 18, 2012
Mergers among generics cos. on the rise

Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry.


© 2013 Drug Store News. All Rights Reserved.